Rocket Pharmaceuticals, Inc.

RCKT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001281895

SEC filings (opens in a new tab)

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of RCKT: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	149	3	147	+1
Shares	64.4M	74.6K	64.8M	+484.3K (+0.8%)
Value	$1.02B	$1.18M	$891.6M	−$127.0M (−12.5%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to RCKT in Q2 2022
Institution	Shares	Value	% of portfolio
GMT Capital Corp	496,800	$6.84M	0.43%
Soleus Capital Management, L.P.	318,100	$4.38M	0.70%
Russell Investments Group, Ltd.	173,316	$2.38M	0.00%
Granite Point Capital Management, L.P.	80,000	$1.10M	0.96%
Cinctive Capital Management LP	80,000	$1.10M	0.05%
Connor, Clark & Lunn Investment Management Ltd.	62,744	$863.0K	0.01%
SG Americas Securities, LLC	49,242	$678.0K	0.01%
Hennion & Walsh Asset Management, Inc.	43,612	$600.0K	0.04%
Gilder Gagnon Howe & Co LLC	29,659	$408.0K	0.01%
New York Life Investment Management LLC	29,403	$405.0K	0.00%
Privium Fund Management B.V.	24,750	$341.0K	0.12%
Quantbot Technologies LP	23,249	$319.0K	0.03%
Gsa Capital Partners LLP	21,289	$293.0K	0.04%
Marshall Wace, LLP	13,800	$190.0K	0.00%
Jane Street Group, LLC	12,996	$179.0K	0.00%
Veritable, L.P.	12,211	$168.0K	0.00%
Baird Financial Group, Inc.	10,661	$147.0K	0.00%
Harbour Investments, Inc.	1,315	$18.0K	0.00%
Simplex Trading, LLC	452	$6.00K	0.00%
TCI Wealth Advisors, Inc.	332	$5.00K	0.00%
Dark Forest Capital Management LP	265	$4.00K	0.00%
Captrust Financial Advisors	104	$1.00K	0.00%
Lindbrook Capital, LLC	88	$1.00K	0.00%

Sold out (22)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of RCKT in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Healthcare of Ontario Pension Plan Trust Fund	391,700	$6.21M
Ghost Tree Capital, LLC	200,000	$3.17M
Woodline Partners LP	142,011	$2.25M
Bollard Group LLC	112,400	$1.78M
HighVista Strategies LLC	48,191	$764.0K
Samsara BioCapital, LLC	40,550	$643.0K
Vontobel Holding Ltd.	36,912	$589.0K
Cubist Systematic Strategies, LLC	34,452	$546.0K
Tudor Investment Corp Et Al	32,787	$520.0K
Squarepoint Ops LLC	28,056	$445.0K
Dynamic Technology Lab Private Ltd	24,408	$387.0K
Fox Run Management, L.L.C.	16,594	$263.0K
Jump Financial, LLC	16,100	$255.0K
Campbell & CO Investment Adviser LLC	14,949	$237.0K
Point72 Hong Kong Ltd	4,408	$70.0K
Allspring Global Investments Holdings, LLC	896	$14.0K
FourThought Financial, LLC	695	$11.0K
Parallel Advisors, LLC	293	$5.00K
Group One Trading, L.P.	88	$1.00K
Bessemer Group Inc	58	$1.00K
Washington Trust Advisors, Inc.	72	$1.00K
Covestor Ltd	13	$0

Not filed for Q2 2022 yet (3)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	43,161	$685.0K
IndexIQ Advisors LLC	24,715	$392.0K
Amalgamated Financial Corp.	6,711	$106.0K